These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22995412)

  • 1. Late acquired double lumina in a sirolimus-eluting stent recanalized chronic total occlusion lesion: angiographic and optical coherence tomographic findings.
    Wu W; Zhang S; Shen Z; Xie H; Fan Z
    Int J Cardiol; 2013 Apr; 165(1):206-8. PubMed ID: 22995412
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stent treatment of left main coronary artery disease: the case for a sirolimus-eluting, autoexpandable alternative. An optical coherence tomography analysis.
    Buccheri D; Orrego PS; Cortese B
    Int J Cardiol; 2015 Nov; 199():119-20. PubMed ID: 26188831
    [No Abstract]   [Full Text] [Related]  

  • 3. Stent collapse after guide extension catheter collision. Signature procedural finding by optical coherence tomography.
    Balleby IR; Terkelsen CJ; Christiansen EH; Holm NR
    Int J Cardiol; 2016 Jan; 202():488-9. PubMed ID: 26440457
    [No Abstract]   [Full Text] [Related]  

  • 4. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
    Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
    Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very late thrombosis after subintimal sirolimus-eluting stent implantation during percutaneous coronary intervention for chronic total occlusion.
    Miyazaki S; Hiasa Y; Kishi K
    J Invasive Cardiol; 2010 Aug; 22(8):E162-5. PubMed ID: 20679685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation.
    Imai M; Kadota K; Goto T; Fujii S; Yamamoto H; Fuku Y; Hosogi S; Hirono A; Tanaka H; Tada T; Morimoto T; Shiomi H; Kozuma K; Inoue K; Suzuki N; Kimura T; Mitsudo K
    Circulation; 2011 May; 123(21):2382-91. PubMed ID: 21576652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worsening late-acquired incomplete stent apposition after sirolimus-eluting stent implantation for a chronic total occlusion lesion.
    Nakazato K; Misaka T; Sakamoto N; Kunii H; Saitoh S; Takeishi Y
    Cardiovasc Interv Ther; 2015 Jan; 30(1):85-91. PubMed ID: 24595874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomographic observations of polytetrafluoroethylene-covered sirolimus-eluting coronary arterial stent.
    Hou J; Jia H; Huang X; Yu H; Ren X; Fang Y; Han Z; Yang S; Meng L; Zhang S; Yu B; Jang IK
    Am J Cardiol; 2013 Apr; 111(8):1117-22. PubMed ID: 23351458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.
    Taniwaki M; Windecker S; Zaugg S; Stefanini GG; Baumgartner S; Zanchin T; Wenaweser P; Meier B; Jüni P; Räber L
    Eur Heart J; 2015 Aug; 36(32):2167-76. PubMed ID: 26040806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
    Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremely late drug-eluting stent thrombosis related to uncovered struts: the phantom menace.
    Spagnoli V; Veugeois A; Caussin C; Amabile N
    Eur Heart J; 2013 Aug; 34(31):2428. PubMed ID: 23821398
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiographically silent very late stent thrombosis detected by optical coherence tomography in association with peri-stent staining and multiple interstrut cavities.
    Cassar A; Gulati R; Matsuo Y; Bresnahan JF; Prasad A
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):603. PubMed ID: 23258315
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
    Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of intra-coronary optical coherence tomography for the assessment of sirolimus-eluting stent fracture.
    Barlis P; Sianos G; Ferrante G; Del Furia F; D'Souza S; Di Mario C
    Int J Cardiol; 2009 Jul; 136(1):e16-20. PubMed ID: 18723234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency-domain optical coherence tomography assessment of stent constriction 9 months after sirolimus-eluting stent implantation in a highly calcified plaque.
    Fujino Y; Attizzani GF; Nakamura S; Costa MA; Bezerra HG
    JACC Cardiovasc Interv; 2013 Feb; 6(2):204-5. PubMed ID: 23428015
    [No Abstract]   [Full Text] [Related]  

  • 18. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete arterial healing 8 years after the implantation of sirolimus-eluting stent. In vivo visualization by optical coherence tomography.
    Bouki KP; Sakkali EK; Apostolou TS
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):625-7. PubMed ID: 21735524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Images in cardiovascular medicine: Late abnormal vessel wall reaction 3 years after sirolimus-eluting stent implantation.
    Kawaguchi R; Jingu M; Yamashita E; Toyama T; Hoshizaki H; Oshima S
    Circulation; 2009 Sep; 120(9):e65. PubMed ID: 19720941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.